Thyroid cancer (TC) is a significant global healthcare burden. However, the lack of
comprehensive data has impeded our understanding of its global impact. We aimed to …

ABSTRACT RET gene is a driver of thyroid cancer (TC) tumorigenesis. The incidence of TC
has increased worldwide in the last few decades, both in medullary and follicular‐derived …

Thyroid cancer management is rapidly changing. The identification of actionable biomarkers
through both germline and somatic testing are now an integral part of directing patient …

The prognosis of thyroid cancer in patients varies significantly based on different
pathological types or distinct clinical situations. Investigating the expression of immune …

Background DNA hypermethylation and hotspot mutations were frequently observed in the
upstream and core promoter of telomerase reverse transcriptase (TERT), respectively, and …

Background: Although patients with anaplastic thyroid cancer (ATC) generally have a poor
prognosis and there are currently no effective treatment options, survival and response to …

Background: Anaplastic thyroid cancer (ATC) is a rare but one of the most lethal types of
human cancer. Although increasing evidence demonstrated that ATC tumors had a high …

Immunotherapy has represented a novel and cutting-edge approach to treating patients with
many types of metastatic cancers in recent years, transforming outcomes for patients who …

Thyroid cancer includes papillary thyroid carcinoma (PTC) and anaplastic thyroid carcinoma
(ATC). While PTC has an excellent prognosis, ATC has a dismal prognosis, necessitating …

Background Columnar cell papillary thyroid carcinoma (CC-PTC) is a morphologic subtype
of papillary thyroid carcinoma with a variable prognosis. It is characterized by neoplastic …